SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001338095-14-000012
Filing Date
2014-08-12
Accepted
2014-08-12 16:11:38
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrx0630201410-q.htm 10-Q 611941
2 EXHIBIT 31.1 nrx06302014exhibit311.htm EX-31.1 11824
3 EXHIBIT 31.2 nrx06302014exhibit312.htm EX-31.2 11910
4 EXHIBIT 32 nrx06302014exhibit32.htm EX-32 8329
  Complete submission text file 0001338095-14-000012.txt   3925002

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nrx-20140630.xml EX-101.INS 471304
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nrx-20140630.xsd EX-101.SCH 25775
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nrx-20140630_cal.xml EX-101.CAL 40620
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nrx-20140630_def.xml EX-101.DEF 139904
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nrx-20140630_lab.xml EX-101.LAB 382635
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nrx-20140630_pre.xml EX-101.PRE 219716
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36303 | Film No.: 141034084
SIC: 2834 Pharmaceutical Preparations